Volume 27, Number 9—September 2021
Dispatch
A Community-Adapted Approach to SARS-CoV-2 Testing for Medically Underserved Populations, Rhode Island, USA
Matthew Murphy, Imshan Dhrolia, Alexandra Zanowick-Marr, Jun Tao, Cassie Sutten Coats, Siena Napoleon, Yelena Malyuta, Emily Adams, Trisha Arnold, Philip A. Chan, and Amy Nunn
Table 1
Demographic information for patients undergoing testing for severe acute respiratory syndrome coronavirus 2 at Rhode Island Public Health Institute testing site, Rhode Island, USA, June 8–August 8, 2020*
| Characteristic | Total, n = 498 | SARS-CoV-2–positive patients, n = 26 (5%) |
SARS-CoV-2–negative patients, n = 472 (95%) |
|||
|---|---|---|---|---|---|---|
| Median age (range), y |
36.9 (7–91) |
40.1 (7–91) |
36.7 (11–77) |
|||
| Age group, y | ||||||
| 0–14 | 13 (3) | 1 (4) | 12 (3) | |||
| 15–34 | 262 (53) | 11 (42) | 251 (53) | |||
| 35–64 | 184 (37) | 11 (42) | 173 (37) | |||
| >65 |
39 (8) |
3 (12) |
36 (8) |
|||
| Race | ||||||
| White | 230 (49) | 2 (9) | 228 (51) | |||
| Other race | 123 (26) | 14 (61) | 109 (24) | |||
| Black or African American | 86 (18) | 4 (17) | 82 (18) | |||
| Asian | 26 (6) | 2 (9) | 24 (5) | |||
| American Indian or Alaskan Native | 4 (1) | 1 (4) | 3 (1) | |||
| Unknown or not reported |
29 (6) |
3 (12) |
26 (6) |
|||
| Ethnicity | ||||||
| Not Hispanic or Latinx | 303 (63) | 5 (21) | 298 (65) | |||
| Hispanic or Latinx | 180 (37) | 19 (79) | 161 (35) | |||
| Unknown or not reported |
15 (3) |
2 (8) |
13 (3) |
|||
| Preferred language | ||||||
| English | 392 (79) | 12 (48) | 380 (81) | |||
| Spanish | 102 (21) | 12 (48) | 90 (19) | |||
| Other language | 2 (0) | 1 (4) | 1 (0) | |||
| Unknown or not reported |
2 (0) |
1 (4) |
1 (0) |
|||
| Sex assigned at birth | ||||||
| F | 304 (61) | 9 (36) | 295 (63) | |||
| M | 193 (39) | 16 (64) | 177 (38) | |||
| Unknown or not reported |
1 (0) |
1 (4) |
0 |
|||
| Gender identity (grouped) | ||||||
| Woman | 225 (52) | 9 (41) | 216 (53) | |||
| Man | 155 (36) | 13 (59) | 142 (35) | |||
| Nonbinary, genderqueer, nonconforming, or agender | 46 (11) | 0 | 46 (11) | |||
| Not listed or other | 5 (1) | 0 | 5 (1) | |||
| Unknown or not reported |
67 (13) |
4 (15) |
63 (13) |
|||
| Sexual orientation | ||||||
| Straight or heterosexual | 260 (60) | 20 (91) | 240 (59) | |||
| Pansexual, queer, asexual, or bisexual | 100 (23) | 0 | 100 (24) | |||
| Lesbian, gay, or homosexual | 57 (13) | 1 (5) | 56 (14) | |||
| Not listed or other | 15 (3) | 1 (5) | 14 (3) | |||
| Unknown or not reported |
66 (13) |
4 (15) |
62 (13) |
|||
| Clinical manifestation | ||||||
| Asymptomatic | 369 (90) | 14 (78) | 355 (91) | |||
| Symptomatic | 39 (10) | 4 (22) | 35 (9) | |||
| Unknown or not reported |
90 (18) |
8 (31) |
82 (17) |
|||
| Insurance package | ||||||
| Commercial or group policy, e.g., HMO, PPO | 307 (62) | 10 (40) | 297 (63) | |||
| No insurance | 116 (23) | 10 (40) | 106 (23) | |||
| Medicaid or Medicare Part B | 73 (15) | 5 (20) | 68 (14) | |||
| Unknown or not reported | 2 (0) | 1 (4) |
1 (0) |
|||
*Values are no. (%) except as indicated. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Page created: June 23, 2021
Page updated: August 18, 2021
Page reviewed: August 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.